MTH1 inhibitor, (S)-Crizotinib, Purity ≥98%

Cat. No.: X24-08-YM180

MTH1 inhibitor, (S)-Crizotinib, Purity ≥98%

Synonym: 1374356-45-2; Ent-crizotinib; 3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yi)pyridin-2-amine; 3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine

  • CAS Number: 1374356-45-2
  • Compound CID: 56671814
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
(S)-Crizotinib, soluble in warmed DMSO and ethanol and insoluble in water, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting MTH1. It targets the MTH1 (cell-free assay).
Molecular Weight
450.34
Molecular Formula
C21H22Cl2FN5O
Targets
MTH1 (Cell-free assay): 72 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO (warmed): 42 mg/mL (93.26 mM); Water: insoluble; Ethanol: 22 mg/mL (48.85 mM)
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
(S)-Crizotinib is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of non-small cell lung cancer (NSCLC) and other cancers with ALK (anaplastic lymphoma kinase) or ROS1 (c-ros oncogene 1) gene rearrangements.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.